Jaffetilchin Investment Partners LLC Sells 8,243 Shares of Baxter International Inc. (NYSE:BAX)

Jaffetilchin Investment Partners LLC cut its stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) by 12.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 57,512 shares of the medical instruments supplier's stock after selling 8,243 shares during the period. Jaffetilchin Investment Partners LLC's holdings in Baxter International were worth $1,969,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Riverview Trust Co boosted its holdings in shares of Baxter International by 5,488.2% in the fourth quarter. Riverview Trust Co now owns 950 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 933 shares during the last quarter. Jones Financial Companies Lllp grew its position in shares of Baxter International by 12.1% during the 4th quarter. Jones Financial Companies Lllp now owns 20,466 shares of the medical instruments supplier's stock valued at $597,000 after acquiring an additional 2,201 shares during the period. E Fund Management Co. Ltd. bought a new stake in shares of Baxter International during the 4th quarter valued at $339,000. Generali Investments CEE investicni spolecnost a.s. bought a new position in Baxter International in the 4th quarter worth $188,000. Finally, Amundi lifted its position in Baxter International by 41.1% during the fourth quarter. Amundi now owns 1,319,274 shares of the medical instruments supplier's stock valued at $39,037,000 after purchasing an additional 384,349 shares in the last quarter. 90.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

BAX has been the subject of several recent research reports. Barclays boosted their price target on Baxter International from $39.00 to $41.00 and gave the company an "overweight" rating in a report on Monday, March 10th. Wall Street Zen raised shares of Baxter International from a "hold" rating to a "buy" rating in a report on Sunday, June 22nd. Morgan Stanley lowered their price target on shares of Baxter International from $30.00 to $28.00 and set an "underweight" rating on the stock in a report on Monday, May 5th. Finally, Wells Fargo & Company reduced their price objective on shares of Baxter International from $36.00 to $33.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $37.25.

Baxter International Price Performance

NYSE BAX traded down $0.06 during trading on Monday, hitting $30.33. 2,909,184 shares of the stock traded hands, compared to its average volume of 4,374,627. Baxter International Inc. has a 12-month low of $26.25 and a 12-month high of $40.49. The company has a quick ratio of 1.40, a current ratio of 2.02 and a debt-to-equity ratio of 1.33. The firm has a 50-day simple moving average of $30.52 and a 200-day simple moving average of $31.20. The company has a market capitalization of $15.56 billion, a P/E ratio of -27.57, a price-to-earnings-growth ratio of 0.89 and a beta of 0.61.

Baxter International (NYSE:BAX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.62 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.14. The business had revenue of $2.63 billion for the quarter, compared to analysts' expectations of $2.59 billion. Baxter International had a negative net margin of 4.71% and a positive return on equity of 17.24%. The business's revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.65 earnings per share. As a group, analysts predict that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Friday, May 30th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date is Friday, May 30th. Baxter International's dividend payout ratio (DPR) is presently -61.82%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.